Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography-Reference-Cited by-同舟云学术

Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography

Published:2015-05 Issue:1 Volume:240 Page:216-221
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Othman Alaa,Saely Christoph H.,Muendlein Axel,Vonbank Alexander,Drexel Heinz,von Eckardstein Arnold,Hornemann Thorsten^ORCID

Funder

Zurich Center of Integrated Human Physiology

7th Framework Program of the European Commission

“radiz”—Rare Disease Initiative Zurich

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Sphingolipids and atherosclerosis;Hornemann;Atherosclerosis,2013

2. Plasma sphingomyelin level as a risk factor for coronary artery disease;Jiang;Arterioscler. Thromb. Vasc. Biol.,2000

3. Plasma sphingomyelin and subclinical atherosclerosis: findings from the multi-ethnic study of atherosclerosis;Nelson;Am. J. Epidemiol.,2006

4. Many ceramides;Hannun;J. Biol. Chem.,2011

5. Cloning and initial characterization of a new subunit for mammalian serine-palmitoyltransferase;Hornemann;J. Biol. Chem.,2006

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging role of sphingolipids and extracellular vesicles in development and therapeutics of cardiovascular diseases;IJC Heart & Vasculature;2024-08

2. ReTimeML: a retention time predictor that supports the LC–MS/MS analysis of sphingolipids;Scientific Reports;2024-02-22

3. Circulating sphingolipids in heart failure;Frontiers in Cardiovascular Medicine;2023-05-09

4. Plasma lipidomic profiling reveals metabolic adaptations to pregnancy and signatures of cardiometabolic risk: a preconception and longitudinal cohort study;BMC Medicine;2023-02-13

5. Beyond HDL-Cholesterol: The Search for Functional Biomarkers of High Density Lipoproteins;CardioMetabolic Syndrome Journal;2022